BEHANDLUNG VON CHOLANGITIS MIT SELADELPAR
European patent · EP4225291 · In force
Register entry
- Publication number
- EP4225291
- Application number
- EP22704693
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 29, 2022
- Published
- Aug 16, 2023
- Granted
- Mar 13, 2024
- Protection ends at the latest
- Jan 28, 2042
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 31/192 (2006.01)A61P 1/16 (2006.01)A61K 45/06 (2006.01)
- Priority
- US 202163144355 P 01.02.2021
- PCT application
- PCT/US2022/014464 29.01.2022
- PCT publication
- WO2022/165288 04.08.2022
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 1, 2026
Change
Published in Swissreg on 01.02.2026
- Feb 1, 2025
Change
Published in Swissreg on 01.02.2025
- Jan 22, 2025
Change
Published in Swissreg on 22.01.2025
- May 15, 2024
Agent entered
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 15.05.2024
- Mar 13, 2024
Granted
Published in Swissreg on 13.03.2024
Parties
Inventor
YANG, Ke
Newark, CA 94560, US
STEINBERG, Alexandra S.
Newark, CA 94560, US
MCWHERTER, Charles A.
Newark, CA 94560, US
CHOI, Yun-Jung
Newark, CA 94560, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.